Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Clinical Research Coordinator (Lung Team) - 40360 University Staff Description University of Colorado Anschutz Medical Campus Department: Cancer Center – CCTO (Lung Team) Working Title: Clinical Research Coordinator (Lung Team) Position #: 00680442 – Requisition #: 40360 Job Summary:
Clinical Research Coordinator (Lung Team)( Job Number: 40360) Description University of Colorado Anschutz Medical Campus Department: Cancer Center – CCTO (Lung Team) Working Title: Clinical Research Coordinator (Lung Team) Position #: 00680442 – Requisition #: 40360 Job Summary: Clinical
Regeneron is growing its newly established International Oncology organisation and is seeking a Sales Specialist to join the UK sales team. This role focuses on engaging oncology healthcare professionals, supporting effective clinical practice through high‑quality scientific
Thanks for your interest in Childrens Mercy! Do you envision finding a meaningful role with an inclusive and compassionate team? At Children’s Mercy, we believe in making a difference in the lives of all children and
The Job Details are as follows: Who We Are We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter
Role Summary Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major
By clicking the “Apply” button, I understand that my employment application process with Takeda will commence and that the information I provide in my application will be processed in line with Takeda’s Privacy Notice and Terms
We anticipate the application window for this opening will close on - 17 Jul 2026 Careers that change lives start here. Medtronic is a global leader in healthcare technology with a Mission to alleviate pain, restore
Career CategoryMarketing Job Description At Amgen, if you feel like you are part of something bigger, it is because you are. Our shared mission - to serve patients living with serious illnesses - drives all that
Under the direction of the Director of Pharmacy and Pharmacy leadership, the Clinical and Financial Access Coordinator supports patients and clinical teams by facilitating access to medications through insurance prior authorizations, benefits investigations, scheduling coordination, care
This position is a senior level analyst position responsible for acquiring in-depth knowledge of the application, their software, architecture as well as any interdependencies in the Mount Sinai landscape. It also entails working independently in completing